Pharma Strategy and Competitive Intelligence

Business intelligence in a biotechnology world

Pharma Strategy and Competitive Intelligence header image 4

Entries from October 24th, 2008

Useful sources of competitive intelligence

October 24th, 2008 · No Comments · Uncategorized

For those interested in business and competitive intelligence, take a look at the Society of Competitive Intelligence Professionals (SCIP). It’s open to all industries, not just pharmaceuticals and biotechnology. There is also a useful portal on Ning, many of whom are SCIP members.

[Read more →]

Tags:·

Increasing importance of competitive intelligence in bear markets

October 18th, 2008 · No Comments · Market research, biotech, brain cancer, competitive intelligence, marketing, oncology, pharma

In tough economic times, many companies are forced to downsize, trim budgets and preserve profit margins, while expecting a leaner, meaner organisation to survive the tempest. The reality is that the changes leave fewer people to accomplish the same amount of work on less marketing dollars; productivity becomes the new name of the game. This [...]

[Read more →]

Tags:

Using social media tools for competitive intelligence

October 17th, 2008 · No Comments · FriendFeed, Google Reader, Twitter, biotechnology, cancer, competitive intelligence, pharma strategy

The last few years have seen a rise in all sorts of web 2.0 social media tools, so much so that the choices are becoming rapidly bewildering. They range from old stalwarts such as LinkedIn, Facebook and Ning to new kids on the block such as Twitter and FriendFeed. Image via CrunchBaseTwitter is a microblogging [...]

[Read more →]

Tags:

Procrit linked to deaths in stroke patients

October 1st, 2008 · No Comments · Epoetin alfa, FDA, Food and Drug Administration, competitive intelligence, pharma, strategy

Johnson and Johnson’s Ortho Biotech has informed the FDA of preliminary safety findings from a clinical trial conducted in Germany investigating the use of Procrit (epoetin alfa) to treat acute ischemic stroke. The clinical trial utilised doses of Procrit that were considerably higher than the doses recommended for the treatment of anemia as described in [...]

[Read more →]

Tags: